Pharmaceutical Development Group (PDG) assists FDA regulated firms in the navigation of the U.S. submission, approval and post-marketing procedures across a variety of dosage forms and therapeutic areas. Our expertise spans prescription and nonprescription (OTC) drugs, both NDA and monograph, as well as devices. Pharmaceutical regulatory consulting medical device consultant ind consulting 513(g) 510(k) submission pharmaceutical strategy consulting fda drug labeling requirements fda facility inspections nda consulting